Sherry Aulin

Insider Reports History

Entity
Individual
Location
200 3650 Gilmore Way, Burnaby, Alberta, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sherry Aulin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Chief Financial Officer Common Shares 0 $0 $41.19 Dec 18, 2024 Direct
Xenon Pharmaceuticals Inc. Chief Financial Officer Stock Option (Right to Buy) 6K Dec 18, 2024 Direct

Insider Reports Filed by Sherry Aulin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Dec 18, 2024 8 -$771K 4 Dec 19, 2024 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Sep 2, 2022 12 -$608K 4 Sep 7, 2022 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Chief Financial Officer
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 0 $0 3 Jun 3, 2021 Chief Financial Officer